Obstructive sleep apnea and cardio-vascular damage;Obturacyjny bezdech senny a powikałnia w układzie sercowo-naczyniowym

Kardiologia Polska

Volumn 70, Issue 7, 2012, Pages 735-740

  Józwik Plebanek, Katarzyna ^a   Prejbisz, Aleksander ^a   Janaszek Sitkowska, Hanna ^a   Klisiewicz, Anna ^a   Sliwinski, Pawel ^b   Pregowska Chwala, Barbara ^a   Hoffman, Piotr ^a   Januszewicz, Andrzej ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HEART INJURY; HUMAN; REVIEW; SLEEP APNEA SYNDROME; KIDNEY DISEASE; SLEEP DISORDERED BREATHING;

CARDIOVASCULAR DISEASES; HUMANS; KIDNEY DISEASES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84864535164     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation, 2008; 118: 1080-1111.
2. Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med, 2005; 353: 2034-2041. (Pubitemid 41609096)
3. Marshall N, Wong K, Liu P, Cullen SRJ, Knuiman MW. Sleep apnea as an independent risk factor for all- cause mortality: the Busselton Health Study. Sleep, 2008; 31: 1079-1085.
4. Liam S, Doherty MD, Kiely JL et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest, 2005; 127: 2076-2084.
5. Veale D, Chailleux E, Hoorelbeke-Ramon A et al. Mortality of sleep apnea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Lancet, 2005; 365: 1046-1053.
6. Veale D, Chailleux E, Hoorelbeke-Ramon A et al. Mortality of sleep apnea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Eur Respir J, 2000; 15: 326-331. (Pubitemid 30085961)
7. Mancia G, Laurentb S, Agabiti-Rosei E et al. Europejskie zalecenia dotycza̧ce leczenia nadciśnienia tȩtniczego. Stanowisko Europejskiego Towarzystwa Nadciśnienia Tȩtniczego 2009. J Hypertens, 2009; 27: 2121-2158.
8. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 2007; 25: 1105-1187. (Pubitemid 46924065)
9. Widecka K, Grodzicki T, Narkiewicz K et al. Zasady postȩpowania w nadcisnieniu tȩtniczym, 2011 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tȩtniczego. Nadciśnienie Tȩtnicze, 2011; 15: 55-82.
10. Patt BT, Jarjoura D, Haddad DN et al. Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. Am J Respir Crit Care Med, 2010; 182: 1540-1545.
11. Jelic S, Lederer DJ, Adams T et al. Vascular inflammation in obesity and sleep apnea. Circulation, 2010; 121: 1014-1021.
12. Drager LF, Bortolotto LA, Maki-Nunes C et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis, 2010; 208: 490-495.
13. Li C, Zhang XL, Liu H, Wang ZG, Yin KS. Association among plasma interleukin-18 levels, carotid intima- media thickness and severity of obstructive sleep apnea. Chin Med J (Engl), 2009; 122: 24-29.
14. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension and their interaction on arterial stiffness and heart remodeling. Chest, 2007; 131: 1379-1386. (Pubitemid 46762342)
15. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function In obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med, 2004; 169: 348-353. (Pubitemid 38134813)
16. Tanriverdi H, Evrengul H, Kara CO et al. Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration, 2006; 73: 741-750. (Pubitemid 44795919)
17. O'Leary DH, Polak JF, Kronmal RA et al. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 1999; 340: 14-22. (Pubitemid 29024679)
18. Bots ML, Hoes AW, Koudstaal PJ et al. Common carotid intima- media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997; 96: 1432-1437. (Pubitemid 27375333)
19. Baguet JP, Hammer L, Levy P et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest, 2005; 128: 3407-3412. (Pubitemid 41698671)
20. Szaboova E, Tomori Z, Donic V, Petrovicova J, Szabo P. Sleep apnoea inducing hypoxemia is associated with early signs of carotid atherosclerosis in males. Res Physio Neurobiol, 2007; 155: 121-127. (Pubitemid 46136103)
21. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke, 2002; 33: 1782-1785. (Pubitemid 34761060)
22. Saletu M, Nosiska D, Kapfhammer G et al. Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol, 2006; 253: 746-752. (Pubitemid 43980146)
23. Minoguchi K, Yokoe T, Tazaki T et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med, 2005; 172: 625-630. (Pubitemid 41232975)
24. Yun CH, Jung KH, Chu K et al. Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. J Clin Neurol, 2010; 6: 89-98.
25. Protogerou AD, Laaban JP, Czernichow S et al. Structural and functional arterial properties in patients with obstructive sleep apnoea syndrome and cardiovascular comorbidities. J Hum Hypertes, 2008; 22: 415-422. (Pubitemid 351712388)
26. Suzuki T, Nakano H, Maekawa J et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep, 2004; 27: 129-133. (Pubitemid 43906324)
27. Florczak E, Januszewicz A, Prejbisz A et al. Relationship between sleep apnea and target organ damage in never treated hypertensive patients. J Hypertens, 2010; 28: e591.
28. Wattanakit K, Boland L, Punjabi NM, Shahar E. Relation of sleep-disordered breathing to carotid plaque and intima-media thickness. Atherosclerosis, 2008; 197: 125-131. (Pubitemid 351273231)
29. Drager LF, Bortolotto LA, Krieger EM, Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension, 2009; 53: 64-69.
30. Drager LF, Diegues-Silva L, Diniz PM et al. Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens, 2010; 23: 249-254.
31. Moro JA, Almenar L, Fernández-Fabrellas E, Ponce S, Blanquer R, Salvador A. Analysis of echocardiographic alterations observed in sleep apnea-hypopnea syndrome and how they are influenced by hypertension. Rev Esp Cardiol, 2008; 61: 49-57. (Pubitemid 351573758)
32. Shivalkar B, Van de Heyning C, Kerremans M et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol, 2006; 47: 1433-1439.
33. Cioffi G, Russo TE, Stefenelli C et al. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens, 2010; 28: 1074-1082.
34. Tavil Y, Kanbay A, Sen N et al. The relationship between aortic stiffness and cardiac function in patients with obstructive sleep apnea, independently from systemic hypertension. J Am Soc Echocardiogr, 2007; 20: 366-372. (Pubitemid 46497620)
35. Chami HA, Devereux RB, Gottdiener JS et al. Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation, 2008; 117: 2599-2607.
36. Drager LF, Bortolotto LA, Figuereido AC et al. Obstructive sleep apnea, hypertension and their interaction on arterial stiffness and heart remodeling. Chest, 2007; 131: 1379-1386. (Pubitemid 46762342)
37. Cioffi G, Russo TE, Selmi A, Stefenelli C, Furlanello F. Analysis of left ventricular systolic function by midwall mechanics in patients with obstructive sleep apnoea. Eur J Echocardiogr, 2011; 12: 61-68.
38. Kaneko Y, Floras J, Phil D et al. Cardiovascular effects on continous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med, 2003; 348: 1233-1241. (Pubitemid 36359299)
39. Fung JWH, Li T, Choy D et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest, 2002; 121: 422-429. (Pubitemid 34132978)
40. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function. Effects of nasal continuous positive airway pressure in men. Circulation, 2005; 112: 375-383. (Pubitemid 41022078)
41. Gami AS, Hodge DO, Herges RM et al. Obstructive sleep apnea, obesity and the risk of incident atrial fibrillation. J Am Coll Cardiol, 2007; 49: 565-571. (Pubitemid 46177437)
42. Kanagala R, Murali NS, Friedman PA et al. Obstructive sleep apnea and the recurrence of artial fibrillation. Circulation, 2003; 107: 2589-2594. (Pubitemid 36628941)
43. Drager LF, Bortolotto LA, Pedrosa RP, Krieger EM, Lorenzi-Filho G. Left atrial diameter is independently associated with arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. Int J Kardiol, 2010; 144: 257-259.
44. Tsioufis C, Thomopoulos C, Dimitriadis K et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis, 2008; 52: 285-293. (Pubitemid 351978143)
45. Casserly LF, Chow N, Ali S, Gottlieb DJ, Epstein LJ, Kaufman JS. Proteinuria in obstructive sleep apnea. Kidney Int, 2001; 60: 1484-1489. (Pubitemid 32960043)
46. Büchner NJ, Henning BF, Hägele KF, Quack IA, Rump LC. Renal function in hypertensive patients with obstructive sleep apnea. Dtsch Med Wochenschr, 2004; 129: 305-309. (Pubitemid 38250546)
47. Dwivedi G, Khair O, Lip GY. Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin? J Hum Hypertens, 2008; 22: 377-379. (Pubitemid 351712383)
48. Prejbisz A, Florczak E, Oleksiak P et al. Metabolic Abnormalities in Patients with resistant hypertension: relation to blood pressure levels and obstructive sleep apnea severity: the RESIST-POL study. European Society of Cardiology Congress, 25-29 Aug 2012, Munich, Germany.